- By country
- By industry
- By topic
- Top 100
SOFIA (Bulgaria), September 20 (SeeNews) - Bulgaria's Financial Supervision Commission (FSC) said that it has approved the prospectus of local drug trader Sopharma Trading [BUL:SO5] for a capital increase via the issuance of up to 1,371,042 new shares.
Sopharma Trading will offer the shares for subscription at a price of 6.85 levs apiece, the financial regulator said in a statement on Thursday.
If the issue is fully subscribed, the company will raise some 9.4 million levs.
Sopharma Trading shares closed at a price of 6.25 levs on the Bulgarian Stock Exchange on Thursday.
The company's capital currently amounts to 32.9 million levs, divided into the same number of shares.
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)